Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Sex Differences in Coronary Artery Disease: Insights From the KoRean wOmen'S chest pain rEgistry (KoROSE)

  • Hack-Lyoung Kim (Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center) ;
  • Myung-A Kim (Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center)
  • Received : 2023.08.02
  • Accepted : 2023.08.08
  • Published : 2023.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Interest in sex differences in coronary artery disease (CAD) has been steadily increasing. Concurrently, most of the data on these differences have primarily been Western-oriented. The KoRean wOmen'S chest pain rEgistry (KoROSE), started in 2011, has since published numerous research findings. This review aims to summarize the reported differences between men and women in CAD, integrating data from KoROSE. Cardiovascular risk in postmenopausal women escalates dramatically due to the decrease in estrogen levels, which normally offer cardiovascular protective effects. Lower estrogen levels can lead to abdominal obesity, insulin resistance, increased blood pressure, and endothelial dysfunction in older women. Upon analyzing patients with CAD, women are typically older and exhibit more cardiovascular risk factors than men. Diagnosing CAD in women tends to be delayed due to their symptoms being more atypical than men's. While in-hospital outcome was similar between sexes, bleeding complications after percutaneous coronary intervention occur more frequently in women. The differences in long-term prognosis for CAD patients between men and women are still a subject of ongoing debate. Pregnancy and reproductive factors also play a significant role as risk factors for cardiovascular disease in women. A notable sex disparity exists, with women found to use fewer cardiovascular protective drugs and undergo fewer interventional or surgical procedures than men. Additionally, women participate less frequently than men in clinical research. Through concerted efforts to increase awareness of sex differences and mitigate sex disparity, personalized treatment can be provided. This approach can ultimately improve patient prognosis.

Keywords

References

  1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 2023;147:e93-621.
  2. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-41. https://doi.org/10.1056/NEJMoa1008862
  3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. https://doi.org/10.1016/S0140-6736(02)11911-8
  4. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-96. https://doi.org/10.1016/S0140-6736(09)60318-4
  5. Prospective Studies Collaboration, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39. https://doi.org/10.1016/S0140-6736(07)61778-4
  6. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-50. https://doi.org/10.1056/NEJMsa1211128
  7. Arafa A, Lee HH, Eshak ES, et al. Modifiable risk factors for cardiovascular disease in Korea and Japan. Korean Circ J 2021;51:643-55. https://doi.org/10.4070/kcj.2021.0121
  8. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;74:1376-414. https://doi.org/10.1016/j.jacc.2019.03.009
  9. Visseren FL, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-337. https://doi.org/10.1093/eurheartj/ehab484
  10. Kim HL, Chung J, Kim KJ, et al. Lifestyle modification in the management of metabolic syndrome: statement from Korean Society of CardioMetabolic Syndrome (KSCMS). Korean Circ J 2022;52:93-109. https://doi.org/10.4070/kcj.2021.0328
  11. Baek J, Lee H, Lee HH, Heo JE, Cho SM, Kim HC. Thirty-six year trends in mortality from diseases of circulatory system in Korea. Korean Circ J 2021;51:320-32. https://doi.org/10.4070/kcj.2020.0424
  12. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904. https://doi.org/10.1001/jama.290.7.898
  13. Lee HH, Cho SM, Lee H, et al. Korea heart disease fact sheet 2020: analysis of nationwide data. Korean Circ J 2021;51:495-503. https://doi.org/10.4070/kcj.2021.0097
  14. Agarwala A, Goldberg A. Special considerations for lipid-lowering therapy in women reflecting recent randomized trials. Curr Atheroscler Rep 2021;23:42.
  15. Mosca L, Hammond G, Mochari-Greenberger H, et al. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation 2013;127:1254-63, e1-29.
  16. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018;137:e67-492. https://doi.org/10.1161/CIR.0000000000000573
  17. Women's Heart Disease Research Working Group (KR). Women's Heart Disease Research Working Group's homepage [Internet]. Incheon: Women's Heart Disease Research Working Group; 2023 [cited 2023 July 18]. Available from: https://www.womensheart.or.kr/. 
  18. Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 2021;397:2385-438. https://doi.org/10.1016/S0140-6736(21)00684-X
  19. Statistics Korea. Causes of death statistics [Internet]. Daejeon: Statistics Korea; c2023 [cited 2023 July 18]. Available from: https://kostat.go.kr/ansk/. 
  20. North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res 2012;110:1097-108. https://doi.org/10.1161/CIRCRESAHA.111.246876
  21. Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med 2009;25:563-77. https://doi.org/10.1016/j.cger.2009.07.007
  22. Centers for Disease Control and Prevention; National Center for Health Statistics. Summary health statistics: National Health Interview Survey, 2018: table A-1 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2018 [cited 2022 March 22]. Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-1.pdf. 
  23. Kim HL, Kim HJ, Kim M, et al. Sex differences in coronary angiographic findings in patients with stable chest pain: analysis of data from the KoRean wOmen'S chest pain rEgistry (KoROSE). Biol Sex Differ 2022;13:2.
  24. Kim HL, Jang JS, Kim MA, et al. Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Medicine (Baltimore) 2019;98:e15557.
  25. Korea Acute Myocardial Infarction Registry (KAMIR) Investigators, Lee KH, Jeong MH, et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008;130:227-34. https://doi.org/10.1016/j.ijcard.2007.08.044
  26. Kunadian V, Qiu W, Lagerqvist B, et al. Gender differences in outcomes and predictors of all-cause mortality after percutaneous coronary intervention (data from United Kingdom and Sweden). Am J Cardiol 2017;119:210-6. https://doi.org/10.1016/j.amjcard.2016.09.052
  27. Jacobs AK, Johnston JM, Haviland A, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. J Am Coll Cardiol 2002;39:1608-14. https://doi.org/10.1016/S0735-1097(02)01835-1
  28. Iyanoye A, Moreyra AE, Swerdel JN, et al. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2015;86:221-8. https://doi.org/10.1002/ccd.25837
  29. Kim HC, Lee H, Lee HH, et al. Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women. Clin Hypertens 2022;28:1.
  30. Brahmbhatt Y, Gupta M, Hamrahian S. Hypertension in premenopausal and postmenopausal women. Curr Hypertens Rep 2019;21:74.
  31. Seo E, Jung S, Lee H, Kim HC. Sex-specific trends in the prevalence of hypertension and the number of people with hypertension: analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 1998-2018. Korean Circ J 2022;52:382-92. https://doi.org/10.4070/kcj.2021.0347
  32. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 2009;54:1561-75. https://doi.org/10.1016/j.jacc.2009.04.098
  33. Park J, Kim HL, Kim MA, et al. Traditional cardiovascular risk factors and obstructive coronary disease in patients with stable chest pain: gender-specific analysis. Cardiometab Syndr J 2021;1:101-10. https://doi.org/10.51789/cmsj.2021.1.e7
  34. Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004;27:2898-904. https://doi.org/10.2337/diacare.27.12.2898
  35. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-8. https://doi.org/10.1136/bmj.38678.389583.7C
  36. Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol 2018;6:538-46. https://doi.org/10.1016/S2213-8587(18)30079-2
  37. Lu Y, Zhou S, Dreyer RP, et al. Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: results from the VIRGO study. Am Heart J 2017;183:74-84. https://doi.org/10.1016/j.ahj.2016.09.012
  38. Rhee EJ. Prevalence and current management of cardiovascular risk factors in Korean adults based on fact sheets. Endocrinol Metab 2020;35:85-94. https://doi.org/10.3803/EnM.2020.35.1.85
  39. Peters SA, Muntner P, Woodward M. Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation 2019;139:1025-35. https://doi.org/10.1161/CIRCULATIONAHA.118.035550
  40. Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas 1999;33:259-69. https://doi.org/10.1016/S0378-5122(99)00054-7
  41. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971;74:1-12. https://doi.org/10.7326/0003-4819-74-1-1
  42. Grundtvig M, Hagen TP, German M, Reikvam A. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil 2009;16:174-9. https://doi.org/10.1097/HJR.0b013e328325d7f0
  43. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297-305. https://doi.org/10.1016/S0140-6736(11)60781-2
  44. Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 2013;44:2821-8. https://doi.org/10.1161/STROKEAHA.113.002342
  45. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998;316:1043-7. https://doi.org/10.1136/bmj.316.7137.1043
  46. Kim YH, Her AY, Jeong MH, et al. Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: results of KAMIR registry. Cardiol J 2022;29:954-65. https://doi.org/10.5603/CJ.a2020.0185
  47. Pirie K, Peto R, Reeves GK, Green J, Beral V; Million Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013;381:133-41. https://doi.org/10.1016/S0140-6736(12)61720-6
  48. Woodward M, Lam TH, Barzi F, et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol 2005;34:1036-45. https://doi.org/10.1093/ije/dyi104
  49. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81. https://doi.org/10.1016/S0140-6736(14)60460-8
  50. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-62.  https://doi.org/10.1172/JCI111040
  51. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008;117:1658-67. https://doi.org/10.1161/CIRCULATIONAHA.107.739714
  52. Cho JH, Kim HL, Kim MA, et al. Association between obesity type and obstructive coronary artery disease in stable symptomatic postmenopausal women: data from the KoRean wOmen'S chest pain rEgistry (KoROSE). Menopause 2019;26:1272-6. https://doi.org/10.1097/GME.0000000000001392
  53. Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006;355:779-87. https://doi.org/10.1056/NEJMoa054017
  54. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95. https://doi.org/10.1056/NEJMra043430
  55. Chung J, Min KW, Son BK, Kim DH, Kim HL. Association between histological severity of Helicobacter pylori infection and cardiovascular risk scores in the Korean population. Atherosclerosis 2021;333:124-30. https://doi.org/10.1016/j.atherosclerosis.2021.08.019
  56. Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 2015;36:482-489c.
  57. Di Florio DN, Sin J, Coronado MJ, Atwal PS, Fairweather D. Sex differences in inflammation, redox biology, mitochondria and autoimmunity. Redox Biol 2020;31:101482.
  58. Kim HL, Kim MA, Oh S, et al. Sex differences in traditional and nontraditional risk factors for obstructive coronary artery disease in stable symptomatic patients. J Womens Health (Larchmt) 2019;28:212-9. https://doi.org/10.1089/jwh.2017.6834
  59. Wang TJ, Larson MG, Levy D, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002;106:1189-91. https://doi.org/10.1161/01.CIR.0000032135.98011.C4
  60. Khera A, de Lemos JA, Peshock RM, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38-43. https://doi.org/10.1161/CIRCULATIONAHA.105.575241
  61. Yamashita T, Sasaki N, Kasahara K, Hirata K. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease. J Cardiol 2015;66:1-8. https://doi.org/10.1016/j.jjcc.2015.02.002
  62. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202. https://doi.org/10.1001/jama.289.2.194
  63. Liu S, Moussa M, Wassef AW, Hiebert BM, Hussain F, Jassal DS. The utility of systolic and diastolic echocardiographic parameters for predicting coronary artery disease burden as defined by the SYNTAX score. Echocardiography 2016;33:14-22. https://doi.org/10.1111/echo.12995
  64. Lin FY, Zemedkun M, Dunning A, et al. Extent and severity of coronary artery disease by coronary CT angiography is associated with elevated left ventricular diastolic pressures and worsening diastolic function. J Cardiovasc Comput Tomogr 2013;7:289-96.e1. https://doi.org/10.1016/j.jcct.2013.08.008
  65. Ohara T, Little WC. Evolving focus on diastolic dysfunction in patients with coronary artery disease. Curr Opin Cardiol 2010;25:613-21. https://doi.org/10.1097/HCO.0b013e32833f0438
  66. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320-8. https://doi.org/10.1016/S0195-668X(02)00428-1
  67. Kim HM, Kim HL, Kim MA, et al. Additional roles of diastolic parameters in the diagnosis of obstructive coronary artery disease. Coron Artery Dis 2021;32:145-51. https://doi.org/10.1097/MCA.0000000000000970
  68. Kim HL, Kim MA, Oh S, et al. Sex difference in the association between metabolic syndrome and left ventricular diastolic dysfunction. Metab Syndr Relat Disord 2016;14:507-12. https://doi.org/10.1089/met.2016.0078
  69. Kim HL, Lim WH, Seo JB, et al. Association between arterial stiffness and left ventricular diastolic function in relation to gender and age. Medicine (Baltimore) 2017;96:e5783.
  70. Kim M, Kim HL, Lim WH, et al. Association between arterial stiffness and left ventricular diastolic function: a large population-based cross-sectional study. Front Cardiovasc Med 2022;9:1001248.
  71. Kim KJ, Kim HL, Kim MJ, et al. Gender difference in the association between aortic pulse pressure and left ventricular filling pressure in the elderly: an invasive hemodynamic study. J Card Fail 2017;23:224-30. https://doi.org/10.1016/j.cardfail.2017.01.001
  72. Cho DH, Kim MA, Choi J, et al. Sex differences in the relationship between left ventricular diastolic dysfunction and coronary artery disease: from the Korean Women's Chest Pain Registry. J Womens Health (Larchmt) 2018;27:912-9. https://doi.org/10.1089/jwh.2017.6610
  73. Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2000;160:1761-8. https://doi.org/10.1001/archinte.160.12.1761
  74. Steptoe A, Kivimaki M. Stress and cardiovascular disease. Nat Rev Cardiol 2012;9:360-70. https://doi.org/10.1038/nrcardio.2012.45
  75. Wei J, Rooks C, Ramadan R, et al. Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease. Am J Cardiol 2014;114:187-92. https://doi.org/10.1016/j.amjcard.2014.04.022
  76. Aboa-Eboule C, Brisson C, Maunsell E, et al. Job strain and risk of acute recurrent coronary heart disease events. JAMA 2007;298:1652-60. https://doi.org/10.1001/jama.298.14.1652
  77. Vaccarino V, Sullivan S, Hammadah M, et al. Mental stress-induced-myocardial ischemia in young patients with recent myocardial infarction: sex differences and mechanisms. Circulation 2018;137:794-805. https://doi.org/10.1161/CIRCULATIONAHA.117.030849
  78. Samad Z, Boyle S, Ersboll M, et al. Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. J Am Coll Cardiol 2014;64:1669-78. https://doi.org/10.1016/j.jacc.2014.04.087
  79. Kim NH, Lee YH, Kim M. Community-dwelling individuals with coronary artery disease have higher risk of depression than the general population in female, but not in male. Korean Circ J 2021;51:752-63. https://doi.org/10.4070/kcj.2021.0009
  80. Cho KI, Shim WJ, Park SM, et al. Association of depression with coronary artery disease and QTc interval prolongation in women with chest pain: data from the KoRean wOmen'S chest pain rEgistry (KoROSE) study. Physiol Behav 2015;143:45-50. https://doi.org/10.1016/j.physbeh.2015.02.048
  81. Almuwaqqat Z, Sullivan S, Hammadah M, et al. Sex-specific association between coronary artery disease severity and myocardial ischemia induced by mental stress. Psychosom Med 2019;81:57-66. https://doi.org/10.1097/PSY.0000000000000636
  82. O'Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res 2022;130:652-72. https://doi.org/10.1161/CIRCRESAHA.121.319895
  83. Canoy D, Beral V, Balkwill A, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation 2015;131:237-44. https://doi.org/10.1161/CIRCULATIONAHA.114.010070
  84. Lee JJ, Cook-Wiens G, Johnson BD, et al. Age at menarche and risk of cardiovascular disease outcomes: findings from the National Heart Lung and Blood Institute-sponsored women's ischemia syndrome evaluation. J Am Heart Assoc 2019;8:e012406.
  85. Kim HL, Kim MA, Shim WJ, et al. Reproductive factors predicting angiographic obstructive coronary artery disease: the KoRean wOmen'S chest pain rEgistry (KoROSE). J Womens Health (Larchmt) 2016;25:443-8. https://doi.org/10.1089/jwh.2015.5381
  86. Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovasc Diabetol 2018;17:37.
  87. Haug EB, Horn J, Markovitz AR, et al. Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Trondelag Health Study. JAMA Cardiol 2019;4:628-35. https://doi.org/10.1001/jamacardio.2019.1746
  88. Sondergaard MM, Hlatky MA, Stefanick ML, et al. Association of adverse pregnancy outcomes with risk of atherosclerotic cardiovascular disease in postmenopausal women. JAMA Cardiol 2020;5:1390-8. https://doi.org/10.1001/jamacardio.2020.4097
  89. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 2019;62:905-14. https://doi.org/10.1007/s00125-019-4840-2
  90. Crump C, Sundquist J, Howell EA, McLaughlin MA, Stroustrup A, Sundquist K. Pre-term delivery and risk of ischemic heart disease in women. J Am Coll Cardiol 2020;76:57-67. https://doi.org/10.1016/j.jacc.2020.04.072
  91. Li W, Ruan W, Lu Z, Wang D. Parity and risk of maternal cardiovascular disease: a dose-response meta-analysis of cohort studies. Eur J Prev Cardiol 2019;26:592-602. https://doi.org/10.1177/2047487318818265
  92. Vladutiu CJ, Siega-Riz AM, Sotres-Alvarez D, et al. Parity and components of the metabolic syndrome among US Hispanic/Latina women: results from the Hispanic Community Health Study/Study of Latinos. Circ Cardiovasc Qual Outcomes 2016;9:S62-9. https://doi.org/10.1161/CIRCOUTCOMES.115.002464
  93. Cho DH, Choi J, Kim MN, et al. Gender differences in the presentation of chest pain in obstructive coronary artery disease: results from the KoRean wOmen'S chest pain rEgistry. Korean J Intern Med 2020;35:582-92. https://doi.org/10.3904/kjim.2018.320
  94. Chen W, Woods SL, Puntillo KA. Gender differences in symptoms associated with acute myocardial infarction: a review of the research. Heart Lung 2005;34:240-7. https://doi.org/10.1016/j.hrtlng.2004.12.004
  95. Rubini Gimenez M, Reiter M, Twerenbold R, et al. Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction. JAMA Intern Med 2014;174:241-9. https://doi.org/10.1001/jamainternmed.2013.12199
  96. D'Antono B, Dupuis G, Fortin C, Arsenault A, Burelle D. Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects. Am Heart J 2006;151:813-9. https://doi.org/10.1016/j.ahj.2005.06.028
  97. Devon HA, Rosenfeld A, Steffen AD, Daya M. Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist. J Am Heart Assoc 2014;3:e000586.
  98. Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006;47:S21-9. https://doi.org/10.1016/j.jacc.2004.12.084
  99. van Oosterhout RE, de Boer AR, Maas AH, Rutten FH, Bots ML, Peters SA. Sex differences in symptom presentation in acute coronary syndromes: a systematic review and meta-analysis. J Am Heart Assoc 2020;9:e014733.
  100. Mackay MH, Ratner PA, Johnson JL, Humphries KH, Buller CE. Gender differences in symptoms of myocardial ischaemia. Eur Heart J 2011;32:3107-14. https://doi.org/10.1093/eurheartj/ehr358
  101. Philpott S, Boynton PM, Feder G, Hemingway H. Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study. Soc Sci Med 2001;52:1565-75. https://doi.org/10.1016/S0277-9536(00)00269-0
  102. Arora G, Bittner V. Chest pain characteristics and gender in the early diagnosis of acute myocardial infarction. Curr Cardiol Rep 2015;17:5.
  103. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003. https://doi.org/10.1093/eurheartj/eht296
  104. Mingels AM, Kimenai DM. Sex-related aspects of biomarkers in cardiac disease. Adv Exp Med Biol 2018;1065:545-64. https://doi.org/10.1007/978-3-319-77932-4_33
  105. Kimenai DM, Lindahl B, Jernberg T, Bekers O, Meex SJ, Eggers KM. Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry. Sci Rep 2020;10:15227.
  106. Jernberg T, James S, Lindahl B, et al. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004;25:1486-93. https://doi.org/10.1016/j.ehj.2004.06.017
  107. Chung J, Kim HL, Kim MA, et al. Sex differences in long-term clinical outcomes in patients hospitalized for acute heart failure: a report from the Korean Heart Failure Registry. J Womens Health (Larchmt) 2019;28:1606-13. https://doi.org/10.1089/jwh.2018.7404
  108. Kim HL, Kim MA, Choi DJ, et al. Gender difference in the prognostic value of N-terminal pro-B type natriuretic peptide in patients with heart failure- a report from the Korean Heart Failure Registry (KorHF). Circ J 2017;81:1329-36. https://doi.org/10.1253/circj.CJ-16-1345
  109. Slagman A, Searle J, Vollert JO, et al. Sex differences of troponin test performance in chest pain patients. Int J Cardiol 2015;187:246-51. https://doi.org/10.1016/j.ijcard.2015.03.261
  110. Mieres JH, Gulati M, Bairey Merz N, et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation 2014;130:350-79. https://doi.org/10.1161/CIR.0000000000000061
  111. De Bacquer D, De Backer G, Kornitzer M, Blackburn H. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart 1998;80:570-7. https://doi.org/10.1136/hrt.80.6.570
  112. Greenland P, Xie X, Liu K, et al. Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up. Am J Cardiol 2003;91:1068-74. https://doi.org/10.1016/S0002-9149(03)00150-4
  113. Mieszczanska H, Pietrasik G, Piotrowicz K, McNitt S, Moss AJ, Zareba W. Gender-related differences in electrocardiographic parameters and their association with cardiac events in patients after myocardial infarction. Am J Cardiol 2008;101:20-4. https://doi.org/10.1016/j.amjcard.2007.07.077
  114. Nowinski K, Jensen S, Lundahl G, Bergfeldt L. Changes in ventricular repolarization during percutaneous transluminal coronary angioplasty in humans assessed by QT interval, QT dispersion and T vector loop morphology. J Intern Med 2000;248:126-36. https://doi.org/10.1046/j.1365-2796.2000.00709.x
  115. Cho DH, Choi J, Kim MN, et al. Incremental value of QT interval for the prediction of obstructive coronary artery disease in patients with chest pain. Sci Rep 2021;11:10513.
  116. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998;32:1657-64. https://doi.org/10.1016/S0735-1097(98)00451-3
  117. Kim YH, Shim WJ, Kim MA, et al. Utility of pretest probability and exercise treadmill test in Korean women with suspected coronary artery disease. J Womens Health (Larchmt) 2016;25:617-22. https://doi.org/10.1089/jwh.2015.5242
  118. Choi JO, Shin MS, Kim MJ, et al. Normal echocardiographic measurements in a Korean population study: part I. cardiac chamber and great artery evaluation. J Cardiovasc Ultrasound 2015;23:158-72. https://doi.org/10.4250/jcu.2015.23.3.158
  119. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005;111:682-96. https://doi.org/10.1161/01.CIR.0000155233.67287.60
  120. Marwick TH, Shaw L, Case C, Vasey C, Thomas JD. Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice. Eur Heart J 2003;24:1153-63. https://doi.org/10.1016/S0195-668X(03)00113-1
  121. Kim MN, Kim SA, Kim YH, et al. Head to head comparison of stress echocardiography with exercise electrocardiography for the detection of coronary artery stenosis in women. J Cardiovasc Ultrasound 2016;24:135-43.  https://doi.org/10.4250/jcu.2016.24.2.135
  122. Park SM, Kim MN, Kim SA, et al. Clinical significance of dynamic left ventricular outflow tract obstruction during dobutamine stress echocardiography in women with suspected coronary artery disease. Circ J 2015;79:2255-62. https://doi.org/10.1253/circj.CJ-15-0500
  123. Nguyen PK, Nag D, Wu JC. Sex differences in the diagnostic evaluation of coronary artery disease. J Nucl Cardiol 2011;18:144-52. https://doi.org/10.1007/s12350-010-9315-2
  124. Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 2017;8:33.
  125. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8. https://doi.org/10.1001/jama.282.21.2012
  126. Vasiljevic-Pokrajcic Z, Mickovski N, Davidovic G, et al. Sex and age differences and outcomes in acute coronary syndromes. Int J Cardiol 2016;217 Suppl:S27-31. https://doi.org/10.1016/j.ijcard.2016.06.217
  127. Mrdovic I, Savic L, Asanin M, et al. Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data. Can J Cardiol 2013;29:1097-103. https://doi.org/10.1016/j.cjca.2012.11.013
  128. Lin DS, Lin YS, Lee JK, Kao HL. Sex differences following percutaneous coronary intervention or coronary artery bypass surgery for acute myocardial infarction. Biol Sex Differ 2022;13:18.
  129. Guo Y, Yin F, Fan C, Wang Z. Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention: a systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11644.
  130. Serruys PW, Cavalcante R, Collet C, et al. Outcomes after coronary stenting or bypass surgery for men and women with unprotected left main disease: the EXCEL trial. JACC Cardiovasc Interv 2018;11:1234-43. https://doi.org/10.1016/j.jcin.2018.03.051
  131. Bryce Robinson N, Naik A, Rahouma M, et al. Sex differences in outcomes following coronary artery bypass grafting: a meta-analysis. Interact Cardiovasc Thorac Surg 2021;33:841-7. https://doi.org/10.1093/icvts/ivab191
  132. Lee SH, Choi J, Chang YJ, et al. Sex difference in long-term clinical outcomes after percutaneous coronary intervention: a propensity-matched analysis of National Health Insurance data in Republic of Korea. Catheter Cardiovasc Interv 2021;98:E171-80. https://doi.org/10.1002/ccd.29511
  133. Park DW, Kim YH, Yun SC, et al. Sex difference in clinical outcomes after percutaneous coronary intervention in Korean population. Am Heart J 2014;167:743-52. https://doi.org/10.1016/j.ahj.2013.12.027
  134. Shin ES, Lee CW, Ahn JM, et al. Sex differences in left main coronary artery stenting: different characteristics but similar outcomes for women compared with men. Int J Cardiol 2018;253:50-4. https://doi.org/10.1016/j.ijcard.2017.06.051
  135. Barthelemy O, Degrell P, Berman E, et al. Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis 2015;108:428-36. https://doi.org/10.1016/j.acvd.2015.03.002
  136. Takagi K, Chieffo A, Shannon J, et al. Impact of gender on long-term mortality in patients with unprotected left main disease: the Milan and New-Tokyo (MITO) Registry. Cardiovasc Revasc Med 2016;17:369-74. https://doi.org/10.1016/j.carrev.2016.05.007
  137. Shungin D, Winkler TW, Croteau-Chonka DC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015;518:187-96. https://doi.org/10.1038/nature14132
  138. Kararigas G, Bito V, Tinel H, et al. Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J Am Coll Cardiol 2012;59:410-7. https://doi.org/10.1016/j.jacc.2011.09.054
  139. Goodarzynejad H, Boroumand M, Behmanesh M, Ziaee S, Jalali A. The rs5888 single nucleotide polymorphism in scavenger receptor class B type 1 (SCARB1) gene and the risk of premature coronary artery disease: a case-control study. Lipids Health Dis 2016;15:7.
  140. Hartiala JA, Tang WH, Wang Z, et al. Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease. Nat Commun 2016;7:10558.
  141. Ellis JA, Stebbing M, Harrap SB. Association of the human Y chromosome with high blood pressure in the general population. Hypertension 2000;36:731-3. https://doi.org/10.1161/01.HYP.36.5.731
  142. Uehara Y, Shin WS, Watanabe T, et al. A hypertensive father, but not hypertensive mother, determines blood pressure in normotensive male offspring through body mass index. J Hum Hypertens 1998;12:441-5. https://doi.org/10.1038/sj.jhh.1000646
  143. Ng MK, Quinn CM, McCrohon JA, et al. Androgens up-regulate atherosclerosis-related genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis. J Am Coll Cardiol 2003;42:1306-13. https://doi.org/10.1016/j.jacc.2003.07.002
  144. Abraham G, Havulinna AS, Bhalala OG, et al. Genomic prediction of coronary heart disease. Eur Heart J 2016;37:3267-78. https://doi.org/10.1093/eurheartj/ehw450
  145. Karalis DG, Wild RA, Maki KC, et al. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol 2016;10:833-41. https://doi.org/10.1016/j.jacl.2016.02.016
  146. Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol 1998;31:1103-9. https://doi.org/10.1016/S0735-1097(98)00056-4
  147. Kim HL, Lee Y, Lee JH, Shin JH, Shin J, Sung KC. Lack of the association between height and cardiovascular prognosis in hypertensive men and women: analysis of national real-world database. Sci Rep 2022;12:18953.
  148. Guimaraes PO, Granger CB, Stebbins A, et al. Sex differences in clinical characteristics, psychosocial factors, and outcomes among patients with stable coronary heart disease: insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial. J Am Heart Assoc 2017;6:e006695.
  149. Yang JJ, Yoon HS, Lee SA, et al. Metabolic syndrome and sex-specific socio-economic disparities in childhood and adulthood: the Korea National Health and Nutrition Examination Surveys. Diabet Med 2014;31:1399-409. https://doi.org/10.1111/dme.12525
  150. Wenger NK. Coronary heart disease: an older woman's major health risk. BMJ 1997;315:1085-90. https://doi.org/10.1136/bmj.315.7115.1085
  151. Kaul P, Armstrong PW, Sookram S, Leung BK, Brass N, Welsh RC. Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction. Am Heart J 2011;161:91-7. https://doi.org/10.1016/j.ahj.2010.09.016
  152. Mollmann H, Liebetrau C, Nef HM, Hamm CW. The Swedish paradox: or is there really no gender difference in acute coronary syndromes? Eur Heart J 2011;32:3070-2. https://doi.org/10.1093/eurheartj/ehr375
  153. Truong QA, Murphy SA, McCabe CH, Armani A, Cannon CP; TIMI Study Group. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circ Cardiovasc Qual Outcomes 2011;4:328-36. https://doi.org/10.1161/CIRCOUTCOMES.110.957720
  154. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005;45:832-7. https://doi.org/10.1016/j.jacc.2004.11.055
  155. Bugiardini R, Estrada JL, Nikus K, Hall AS, Manfrini O. Gender bias in acute coronary syndromes. Curr Vasc Pharmacol 2010;8:276-84. https://doi.org/10.2174/157016110790887018
  156. Zhao M, Woodward M, Vaartjes I, et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis. J Am Heart Assoc 2020;9:e014742.
  157. Ter Woorst JF, van Straten AH, Houterman S, Soliman-Hamad MA. Sex difference in coronary artery bypass grafting: preoperative profile and early outcome. J Cardiothorac Vasc Anesth 2019;33:2679-84. https://doi.org/10.1053/j.jvca.2019.02.040
  158. Chen CY, Chuang SY, Fang CC, et al. Gender disparities in optimal lipid control among patients with coronary artery disease. J Atheroscler Thromb 2014;21 Suppl 1:S20-8. https://doi.org/10.5551/jat.21_Sup.1-S20
  159. Kim HJ, Kim HY, Kim HL, et al. Awareness of cardiovascular disease among Korean women: results from a nationwide survey. Prev Med Rep 2022;26:101698.
  160. Tannenbaum C, Norris CM, McMurtry MS. Sex-specific considerations in guidelines generation and application. Can J Cardiol 2019;35:598-605. https://doi.org/10.1016/j.cjca.2018.11.011